113 related articles for article (PubMed ID: 31761062)
1. Neuroimaging of Diseases Causing Dementia.
Masdeu JC
Neurol Clin; 2020 Feb; 38(1):65-94. PubMed ID: 31761062
[TBL] [Abstract][Full Text] [Related]
2. Multimodal PET Imaging of Amyloid and Tau Pathology in Alzheimer Disease and Non-Alzheimer Disease Dementias.
Xia C; Dickerson BC
PET Clin; 2017 Jul; 12(3):351-359. PubMed ID: 28576172
[TBL] [Abstract][Full Text] [Related]
3. Computerized decision support is an effective approach to select memory clinic patients for amyloid-PET.
Rhodius-Meester HFM; van Maurik IS; Collij LE; van Gils AM; Koikkalainen J; Tolonen A; Pijnenburg YAL; Berkhof J; Barkhof F; van de Giessen E; Lötjönen J; van der Flier WM
PLoS One; 2024; 19(5):e0303111. PubMed ID: 38768188
[TBL] [Abstract][Full Text] [Related]
4. Changing Landscapes in the Neuroimaging of Dementia.
Ranganathan LN; Guhan R; Arun Shivaraman MM; Sankar PL; Srinivasan AV; Suriyakumar G; Periakaruppan AL
Ann Indian Acad Neurol; 2018; 21(2):98-106. PubMed ID: 30122833
[TBL] [Abstract][Full Text] [Related]
5. "Association of blood cell indices and anemia with risk of incident dementia": Missing important covariates in MRI analysis may be misleading.
Zhang X; Zhou W
Alzheimers Dement; 2024 Feb; 20(2):1465. PubMed ID: 38009684
[No Abstract] [Full Text] [Related]
6. PET neuroimaging: plenty of studies still need to be performed: comment on Cumming: "PET neuroimaging: the white elephant packs his trunk?".
Horwitz B; Simonyan K
Neuroimage; 2014 Jan; 84():1101-3. PubMed ID: 23954490
[No Abstract] [Full Text] [Related]
7. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission.
Livingston G; Huntley J; Sommerlad A; Ames D; Ballard C; Banerjee S; Brayne C; Burns A; Cohen-Mansfield J; Cooper C; Costafreda SG; Dias A; Fox N; Gitlin LN; Howard R; Kales HC; Kivimäki M; Larson EB; Ogunniyi A; Orgeta V; Ritchie K; Rockwood K; Sampson EL; Samus Q; Schneider LS; Selbæk G; Teri L; Mukadam N
Lancet; 2020 Aug; 396(10248):413-446. PubMed ID: 32738937
[No Abstract] [Full Text] [Related]
8. Dementia care during COVID-19.
Wang H; Li T; Barbarino P; Gauthier S; Brodaty H; Molinuevo JL; Xie H; Sun Y; Yu E; Tang Y; Weidner W; Yu X
Lancet; 2020 Apr; 395(10231):1190-1191. PubMed ID: 32240625
[No Abstract] [Full Text] [Related]
9. Amyloid-PET and
Chételat G; Arbizu J; Barthel H; Garibotto V; Law I; Morbelli S; van de Giessen E; Agosta F; Barkhof F; Brooks DJ; Carrillo MC; Dubois B; Fjell AM; Frisoni GB; Hansson O; Herholz K; Hutton BF; Jack CR; Lammertsma AA; Landau SM; Minoshima S; Nobili F; Nordberg A; Ossenkoppele R; Oyen WJG; Perani D; Rabinovici GD; Scheltens P; Villemagne VL; Zetterberg H; Drzezga A
Lancet Neurol; 2020 Nov; 19(11):951-962. PubMed ID: 33098804
[TBL] [Abstract][Full Text] [Related]
10. [Young onset dementia].
Pawlowski M; Johnen A; Duning T
Nervenarzt; 2020 Oct; 91(10):936-945. PubMed ID: 32725488
[TBL] [Abstract][Full Text] [Related]
11. Neuroimaging in Dementia: A Brief Review.
Banerjee D; Muralidharan A; Hakim Mohammed AR; Malik BH
Cureus; 2020 Jun; 12(6):e8682. PubMed ID: 32699682
[TBL] [Abstract][Full Text] [Related]
12. Functional Connectivity in Neurodegenerative Disorders: Alzheimer's Disease and Frontotemporal Dementia.
Jalilianhasanpour R; Beheshtian E; Sherbaf G; Sahraian S; Sair HI
Top Magn Reson Imaging; 2019 Dec; 28(6):317-324. PubMed ID: 31794504
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology and Pathophysiology of Dementia-Related Psychosis.
Aarsland D
J Clin Psychiatry; 2020 Sep; 81(5):. PubMed ID: 32936544
[TBL] [Abstract][Full Text] [Related]
14. Positron Emission Tomography (PET) and Neuroimaging in the Personalized Approach to Neurodegenerative Causes of Dementia.
Ricci M; Cimini A; Chiaravalloti A; Filippi L; Schillaci O
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33050556
[TBL] [Abstract][Full Text] [Related]
15. Neuroimaging in genetic frontotemporal dementia and amyotrophic lateral sclerosis.
Häkkinen S; Chu SA; Lee SE
Neurobiol Dis; 2020 Nov; 145():105063. PubMed ID: 32890771
[TBL] [Abstract][Full Text] [Related]
16. [MRI in Neurodegenerative Diseases].
Urbach H; Egger K
Fortschr Neurol Psychiatr; 2020 Apr; 88(4):266-284. PubMed ID: 32325519
[TBL] [Abstract][Full Text] [Related]
17. Development of disease-modifying drugs for frontotemporal dementia spectrum disorders.
Panza F; Lozupone M; Seripa D; Daniele A; Watling M; Giannelli G; Imbimbo BP
Nat Rev Neurol; 2020 Apr; 16(4):213-228. PubMed ID: 32203398
[TBL] [Abstract][Full Text] [Related]
18. The characterisation of subjective cognitive decline.
Jessen F; Amariglio RE; Buckley RF; van der Flier WM; Han Y; Molinuevo JL; Rabin L; Rentz DM; Rodriguez-Gomez O; Saykin AJ; Sikkes SAM; Smart CM; Wolfsgruber S; Wagner M
Lancet Neurol; 2020 Mar; 19(3):271-278. PubMed ID: 31958406
[TBL] [Abstract][Full Text] [Related]
19. Recommendations to distinguish behavioural variant frontotemporal dementia from psychiatric disorders.
Ducharme S; Dols A; Laforce R; Devenney E; Kumfor F; van den Stock J; Dallaire-Théroux C; Seelaar H; Gossink F; Vijverberg E; Huey E; Vandenbulcke M; Masellis M; Trieu C; Onyike C; Caramelli P; de Souza LC; Santillo A; Waldö ML; Landin-Romero R; Piguet O; Kelso W; Eratne D; Velakoulis D; Ikeda M; Perry D; Pressman P; Boeve B; Vandenberghe R; Mendez M; Azuar C; Levy R; Le Ber I; Baez S; Lerner A; Ellajosyula R; Pasquier F; Galimberti D; Scarpini E; van Swieten J; Hornberger M; Rosen H; Hodges J; Diehl-Schmid J; Pijnenburg Y
Brain; 2020 Jun; 143(6):1632-1650. PubMed ID: 32129844
[TBL] [Abstract][Full Text] [Related]
20. Challenges and opportunities for improving the landscape for Lewy body dementia clinical trials.
Goldman JG; Forsberg LK; Boeve BF; Armstrong MJ; Irwin DJ; Ferman TJ; Galasko D; Galvin JE; Kaufer D; Leverenz J; Lippa CF; Marder K; Abler V; Biglan K; Irizarry M; Keller B; Munsie L; Nakagawa M; Taylor A; Graham T
Alzheimers Res Ther; 2020 Oct; 12(1):137. PubMed ID: 33121510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
